In April 2025, the EU announced details about the first two medicinal products to undergo joint clinical assessments (JCAs).

One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...

In an interview with former Fox News journalist Megyn Kelly, FDA Commissioner Marty Makary introduced a new mechanism-driven ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

Ipsen and its fellow French partner Genfit are competing with Intercept and Advanz’s Ocaliva, which was approved in 2016 and ...

Shares of OS Therapies rose 19% to $1.78 in premarket trading Tuesday.

The drug received accelerated approval in this indication in 2018. —AstraZeneca and Daiichi Sankyo welcomed European Union approval of Datroway as a treatment for metastatic breast cancer that ...